Navidea reports initial results from phase IIb trial of its beta-amyloid imaging agent NAV-4694 Feb. 7, 2014
Amarantus and Boston University to evaluate test for early signs of neurodegenerative diseases Jan. 31, 2014
OncoCyte commences clinical development of bladder cancer diagnostics in U.S. and China Jan. 29, 2014
RSS